Food Oral Immunotherapy: A Survey Among US Practicing Allergists Conducted as a AAAAI Leadership Institute Project and Work Group Report

被引:5
作者
Anagnostou, Aikaterini [1 ,3 ]
Vickery, Brian [2 ]
机构
[1] Texas Childrens Hosp, Baylor Coll Med, Dept Allergy & Immunol, Houston, TX USA
[2] Emory Univ & Childrens Healthcare Atlanta, Atlanta, GA USA
[3] Texas Children Hosp, Baylor Coll Med, Feigin Ctr, Dept Allergy & Immunol, 1102 Bates Ave, Houston, TX 77030 USA
关键词
Food oral immunotherapy; Survey; Oral food chal-lenge; Children; Practice; Barriers; Academic; Nonacademic settings; QUALITY-OF-LIFE; SUSTAINED UNRESPONSIVENESS; PEANUT; CHILDREN; CHALLENGE; SAFETY; TRENDS; TRIAL;
D O I
10.1016/j.jaip.2023.03.060
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
BACKGROUND: Food oral immunotherapy (OIT) is an active form of treatment for food allergies. Although research in this area has been ongoing for many years, the first US Food and Drug Administrationeapproved product for peanut allergy treatment became available only in January 2020. Limited data exist on OIT services offered by physicians in the United States. OBJECTIVE: This workgroup report was developed to evaluate OIT practices among allergists practicing in the United States. METHODS: The authors developed an anonymous 15-question survey and was subsequently reviewed and approved by the American Academy of Allergy, Asthma & Immunology Practices, Diagnostics and Therapeutics Committee before distribution to the membership. The American Academy of Allergy, Asthma & Immunology electronically distributed the survey to a random sample of 780 members in November 2021. In addition to questions specific to food OIT, the survey included questions on demographics and professional characteristics of the responders. RESULTS: A total of 78 members completed the survey, yielding a 10% response rate. Fifty percent of responders were offering OIT in their practice. There was a significant difference in experience in OIT originating from research trials in academic versus nonacademic centers. Generally, OIT practices were similar in both settings for the number of foods offered, the performance of oral food challenges before initiating treatment, the number of new patients to whom OIT was offered to per month, and age groups OIT to whom was offered. Almost all of the reported barriers to OIT were similar between settings: staff and time limitations, concerns about safety and anaphylaxis, the need for more education on how to perform, inadequate compensation, and that it was not a significant demand from patients. Clinic space limitations were significantly different and more prominent in academic settings. CONCLUSIONS: Our survey revealed interesting trends in the practice of OIT across the United States, with some significant differences arising when academic and nonacademic settings were compared. (c) 2023 American Academy of Allergy, Asthma & Immunology
引用
收藏
页码:2330 / 2334
页数:5
相关论文
共 27 条
[1]   Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial [J].
Anagnostou, Katherine ;
Islam, Sabita ;
King, Yvonne ;
Foley, Loraine ;
Pasea, Laura ;
Bond, Simon ;
Palmer, Chris ;
Deighton, John ;
Ewan, Pamela ;
Clark, Andrew .
LANCET, 2014, 383 (9925) :1297-1304
[2]   Anti-IgE treatment with oral immunotherapy in multifood allergic participants: a double-blind, randomised, controlled trial [J].
Andorf, Sandra ;
Purington, Natasha ;
Block, Whitney M. ;
Long, Andrew J. ;
Tupa, Dana ;
Brittain, Erica ;
Spergel, Amanda Rudman ;
Desai, Manisha ;
Galli, Stephen J. ;
Nadeau, Kari C. ;
Chinthrajah, R. Sharon .
LANCET GASTROENTEROLOGY & HEPATOLOGY, 2018, 3 (02) :85-94
[3]   Safety and feasibility of oral immunotherapy to multiple allergens for food allergy [J].
Begin, Philippe ;
Winterroth, Lisa C. ;
Dominguez, Tina ;
Wilson, Shruti P. ;
Bacal, Liane ;
Mehrotra, Anjuli ;
Kausch, Bethany ;
Trela, Anthony ;
Hoyte, Elisabeth ;
O'Riordan, Gerri ;
Seki, Scott ;
Blakemore, Alanna ;
Woch, Margie ;
Hamilton, Robert G. ;
Nadeau, Kari C. .
ALLERGY ASTHMA AND CLINICAL IMMUNOLOGY, 2014, 10
[4]   AAAAI Work Group Report: Physician Wellness in Allergy and Immunology [J].
Bingemann, Theresa ;
Sharma, Hemant ;
Nanda, Anil ;
Khan, David A. ;
Markovics, Sharon ;
Sussman, James ;
Murphy, Andrew ;
Kalman, Denise ;
Mosnaim, Giselle .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (04) :1224-1229
[5]   Quality of life improves significantly after real-world oral immunotherapy for children with peanut allergy [J].
Blackman, Andrea C. ;
Staggers, Kristen A. ;
Kronisch, Lauren ;
Davis, Carla M. ;
Anagnostou, Aikaterini .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2020, 125 (02) :196-+
[6]   Safety of peanut (Arachis hypogaea) allergen powder-dnfp in children and teenagers with peanut allergy: Pooled summary of phase 3 and extension trials [J].
Brown, Kari R. ;
Baker, James ;
Vereda, Andrea ;
Beyer, Kirsten ;
Burks, A. Wesley ;
du Toit, George ;
Hourihane, Jonathan O'b ;
Jones, Stacie M. ;
Norval, David ;
Dana, Adrian ;
Shreffler, Wayne ;
Vickery, Brian P. ;
Casale, Thomas ;
Skeel, Ben ;
Adelman, Daniel .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (06) :2043-+
[7]   Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study [J].
Chinthrajah, R. Sharon ;
Purington, Natasha ;
Andorf, Sandra ;
Long, Andrew ;
O'Laughlin, Katherine L. ;
Lyu, Shu Chen ;
Manohar, Monali ;
Boyd, Scott D. ;
Tibshirani, Robert ;
Maecker, Holden ;
Plaut, Marshall ;
Mukai, Kaori ;
Tsai, Mindy ;
Desai, Manisha ;
Galli, Stephen J. ;
Nadeau, Kari C. .
LANCET, 2019, 394 (10207) :1437-1449
[8]   Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety [J].
Chu, Derek K. ;
Wood, Robert A. ;
French, Shannon ;
Fiocchi, Alessandro ;
Jordana, Manel ;
Waserman, Susan ;
Brozek, Jan L. ;
Schuenemann, Holger J. .
LANCET, 2019, 393 (10187) :2222-2232
[9]   Dosing, safety, and quality of life after peanut immunotherapy trials: A long-term follow-up study [J].
Cook, Quindelyn ;
Yang, Luanna ;
Hamad, Ahmad ;
Barber, Holly ;
Herlihy, Lauren ;
Burks, A. Wesley ;
Kim, Edwin H. .
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY-IN PRACTICE, 2020, 8 (08) :2805-2807
[10]   Oral immunotherapy for multiple foods in a pediatric allergy clinic setting [J].
Eapen, Amy A. ;
Lavery, William J. ;
Siddiqui, Jaweriah S. ;
Lierl, Michelle B. .
ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2019, 123 (06) :573-+